Empathic Communication Skills (ECS) Training (NCT05456841)
Empathic Communication Skills Training to Reduce Lung Cancer Stigma
🩺 Plain-English Summary (8th-Grade Level)
Research indicates that perceived stigma within medical encounters is prevalent and problematic for lung cancer patients' well-being and quality of cancer care. Promoting empathic communication appears to be a potentially effective intervention target to help reduce patients' perceptions of stigma within clinical encounters; however, no formal trainings exist that focus on teaching empathic communication to oncology care providers (OCPs). Building upon favorable findings from a prior R21 (R21CA202793) and the importance of developing interventions to address lung cancer stigma, our goal is to conduct a national trial of empathic communication skills (ECS) training to facilitate improvements in the medical and psychosocial care of patients through de-stigmatizing interactions with OCPs for patients diagnosed with lung cancer.
Who can join: Review the eligibility criteria below.
Location: Providence St. Joseph Health (Data Collection Only) — Irvine, California
Age range: 18 Years to 100 Years
🧪 Interventions in This Study
- Empathic Communication Skills (ECS) training (BEHAVIORAL)
- Standard of Care participant interaction (OTHER)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (12 Sites)
- Providence St. Joseph Health (Data Collection Only) — Irvine, California
- BAPTIST ALLIANCE - MCI (Data Collection Only) — Miami, Florida
- Advocate Health Care Network — Libertyville, Illinois
- University of Kentucky (Data Collection Only) — Lexington, Kentucky
- Munson Healthcare (Data Collection Only) — Traverse City, Michigan
- Hackensack Meridian Health (Data collection only) — Hackensack, New Jersey
- Roswell Park Cancer Institute (Data Collection Only) — Buffalo, New York
- Memorial Sloan Kettering Cancer Center (All Protocol Activities) — New York, New York
- Virtua Health (Data Collection Only) — Philadelphia, Pennsylvania
- University of Pennsylvania (Data Collection Only) — Philadelphia, Pennsylvania
- Fox Chase Cancer Center (Data Collection Only) — Philadelphia, Pennsylvania
- Chesapeake Regional Healthcare (Data Collection Only) — Chesapeake, Virginia
📞 Contact the Study Coordinator
Phone: (646) 888-0011
Email: banerjes@mskcc.org
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Lung Cancer
- Implementation Strategies for Monitoring Adherence in Real Time — Philadelphia, Pennsylvania
- Early Detection of Lung Cancer — Nashville, Tennessee
- Improving Utilization of Lung Cancer Screening in Underserved PA Populations — Allentown, Pennsylvania
- Effect of Pulmonary Rehabilitation on Surgical Outcomes in the Cancer Setting — Houston, Texas
- Testing the Engaged Approach to Lung Cancer Screening — Denver, Colorado
- Real-Time Image Guided Lymphatic Mapping and Nodal Targeting in Lung Cancer — Boston, Massachusetts
Explore by condition: All Lung Cancer clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.